美股市场个股详情
TEVA 梯瓦制药
- 17.080
- +0.050+0.29%
收盘价 11/21 16:00 (美东)
- 17.213
- +0.133+0.78%
盘后 17:55 (美东)
193.52亿总市值-20094市盈率TTM
17.170最高价16.901最低价834.72万股成交量17.050今开17.030昨收1.42亿成交额0.74%换手率亏损市盈率(静)11.33亿总股本19.31052周最高3.19市净率192.38亿流通值9.35052周最低--股息TTM11.26亿流通股68.007历史最高--股息率TTM1.58%振幅3.107历史最低17.060平均价1股每手
关于梯瓦制药公司
梯瓦制药工业有限公司从事药品的开发、生产和销售。它通过以下地理部分运作:北美，欧洲和国际市场。
公司介绍
公司代码TEVA
公司名称梯瓦制药
上市日期2012/05/30
成立日期1901
CEOMr. Richard D. Francis
所属市场纽交所
员工数量37851
证券类型存托凭证
ADS转换比例1.0 : 1.0
年结日12-31
公司地址124 Dvora HaNevi'a Street
城市特拉维夫
省份特拉维夫
国家以色列
邮编6944020
电话972-3-914-8213
董事高管
- 姓名
- 职务
- 年薪
- Richard D. Francis
- Director, President and Chief Executive Officer
- 2570.69万
- Eli Kalif
- Executive Vice President and Chief Financial Officer
- 494.38万
- Amir Weiss
- Senior Vice President and Chief Accounting Officer
- --
- David R. McAvoy
- Executive Vice President and Chief Legal Officer
- --
- Eric A Hughes
- Executive Vice President, Global R&D and Chief Medical Officer
- --
- Angus Grant
- Executive Vice President, Business Development
- --
- Christine Fox
- Executive Vice President, U.S. Commercial
- --
- Mark Sabag
- Executive Vice President, International Markets Commercial
- 372.91万
- Matthew Shields
- Executive Vice President, Global Operations
- --
- Richard Daniell
- Executive Vice President, European Commercial
- 516.42万
- Dr. Sol J. Barer,PhD
- Chairman of the Board
- 54.00万
- Professor Ronit Satchi-Fainaro
- Independent Director
- 31.52万
- Dr. Tal Zaks, M.D.,PhD
- Independent Director
- 33.00万
- Roberto A. Mignone
- Independent Director
- 34.00万
- Gerald M. Lieberman
- Independent Director
- 35.50万
- Chen Lichtenstein
- Independent Director
- --
- Professor Varda Shalev
- Independent Director
- 17.67万
- Rosemary A. Crane, M.B.A.
- Independent Director
- 33.00万
- Amir Elstein
- Independent Director
- 34.00万
- Janet S. Vergis
- Independent Director
- 32.55万
- Dr. Perry D. Nisen
- Independent Director
- 32.79万
- Vikki L. Conway
- Acting Head of Global Human Resources
- --
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据
